The Ex-A loaded with catalase and sonosensitizer ICG had a high tumor-targeted ability and efficient BBB penetration, as well as a high accumulation in the tumor site, yielding enhanced sonodynamic therapy of glioblastoma [90]. Here, CAT is linked to neoplasm.